EarningsThe updates have increased the price target to $9 from $1, with the largest driver being the 1-for-20 ADS ratio change.
Financial StabilityAmarin currently has a cash position of $281.8M with no debt, which supports continued efforts of the company to maintain prudent cash deployment while pursuing growth for Vazkepa ex-US.
Market ExpansionThere has been a recent uptick in EU Vazkepa revenues driven by broader market access and steady growth in adoption across European countries.